Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Have Declined -19.67% YTD, Forecasting What Will Happen Next
Tarsus Pharmaceuticals Inc (NASDAQ:TARS)’s traded shares stood at 0.85 million during the last session, with the company’s beta value hitting 1.08. At the close of